STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)								12 Months Ended
	Sep. 10, 2025	Feb. 06, 2025	Oct. 04, 2024	Oct. 04, 2024	Oct. 03, 2024	Jun. 07, 2024	Feb. 24, 2023	Dec. 31, 2025	Dec. 31, 2024	May 05, 2025	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock par value								$ 0.0001	$ 0.0001
Common stock, shares authorized								100,000,000	100,000,000
Preferred stock par value								$ 0.0001	$ 0.0001
Preferred stock, shares authorized								10,000,000	10,000,000
Common stock, voting rights								Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so, elect all of the directors of the Company.
Value of shares issued								$ 288,149
Proceeds from warrants exercise									$ 529,050
Share issuance costs									2,999
Total proceeds from issue of shares								$ 288,149
Weighted average life of warrants								2 years 9 months 14 days
Stock-based compensation expense								$ 1,262,355	2,255,413
2025 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares authorized for issuance										2,800,000
Options granted to purchase common shares	1,800,000
Exercise price	$ 0.83
Options vesting term	50
Options expiration date	Sep. 10, 2028
Options exercised								0
Options forfeited								0
Vested options	900,000
Expected life	3 years
Risk-free interest rate	3.47%
Expected dividend yield
Expected share price volatility	138.00%
Grant-date fair value of options	$ 1,039,173
Unrecognized compensation cost								$ 360,152
Weighted-average vesting period								8 months
Intrinsic value
Officer - VP of Operations [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued							2,000,000
Share price							$ 0.70
Fair value of shares							$ 1,400,000
Stock-based compensation expense								$ 116,667	700,000
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued								1,888,890
Share price							$ 0.70
Fair value of shares							$ 1,400,000
Number of shares committed to issue							2,000,000
Unvested compensation related to shares to be issued								$ 77,777
Director And Officer [Member] | 2025 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock-based compensation expense								$ 679,021
Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued			27,356
Purchase Agreement [Member] | Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued		44,431						180,000
Reasonable expenses				$ 20,000
Share issuance costs								$ 5,122	$ 34,000
Share price								$ 1.60
Total proceeds from issue of shares								$ 288,149
Investor [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Commitments description of shares			The Company issued 30% of the Commitment Shares (27,356 shares) on October 4, 2024, and an additional 30% (44,431 shares) on February 6, 2025. The remaining 40% of the Commitment Shares were to be issued to the Investor 180 days after the Commencement Date. The Company also agreed to reimburse the Investor up to $20,000 for reasonable expenses incurred under the Purchase Agreement.
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued						35,000		180,000	455,375
Value of shares issued						$ 100,275		$ 18
Shares issued price per share						$ 2.865
Proceeds from warrants exercise									$ 528,450
Deferred share issuance cost									$ 2,999		$ 18,000
Options exercised									455,375
Common Stock [Member] | Investor [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, consideration received per transaction					$ 25,000,000
Issue to investor			$ 250,000